Search

Your search keyword '"Ramondetta, Lois"' showing total 746 results

Search Constraints

Start Over You searched for: Author "Ramondetta, Lois" Remove constraint Author: "Ramondetta, Lois"
746 results on '"Ramondetta, Lois"'

Search Results

3. Final survival analysis of topotecan and paclitaxel for first-line treatment of advanced cervical Cancer: A NRG oncology randomized study

4. Definitive vs palliative pelvic radiation for patients with newly diagnosed stage IVB cervical cancer treated with bevacizumab – An exploratory study

6. Tumor-resident Lactobacillus iners confer chemoradiation resistance through lactate-induced metabolic rewiring

7. Circulating Tumor Cells In Advanced Cervical Cancer: NRG Oncology—Gynecologic Oncology Group Study 240 (NCT 00803062)

9. Patient-reported outcomes at discontinuation of anti-angiogenesis therapy in the randomized trial of chemotherapy with bevacizumab for advanced cervical cancer: an NRG Oncology Group study.

10. Patient-reported outcomes at discontinuation of anti-angiogenesis therapy in the randomized trial of chemotherapy with bevacizumab for advanced cervical cancer: an NRG Oncology Group study.

12. Serial cytoreductive surgery and survival outcomes in recurrent adult-type ovarian granulosa cell tumors

14. Metagenomes of rectal swabs in larger, advanced stage cervical cancers have enhanced mucus degrading functionalities and distinct taxonomic structure

15. Designing and Implementing an Educational Social Media Campaign to Increase HPV Vaccine Awareness among Men on a Large College Campus

16. Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240)

17. Abstract A077: The utility of surgical minimal residual disease after frontline treatment for prognostic and investigational opportunities in advanced ovarian cancer

19. Dietary Magnesium Replacement for Prevention of Hypomagnesemia in Patients With Ovarian Cancer Receiving Carboplatin-Based Chemotherapy

24. Microbial Diversity and Composition Is Associated with Patient-Reported Toxicity during Chemoradiation Therapy for Cervical Cancer

27. Gut microbiome diversity is an independent predictor of survival in cervical cancer patients receiving chemoradiation

31. Factors Associated With Grade 3 or 4 Treatment-Related Toxicity in Women With Advanced or Recurrent Cervical Cancer

32. Prospective pilot trial with combination of propranolol with chemotherapy in patients with epithelial ovarian cancer and evaluation on circulating immune cell gene expression

37. ConCerv: a prospective trial of conservative surgery for low-risk early-stage cervical cancer

43. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

44. Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images

45. Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers

46. Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context

47. Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas

48. Integrated Genomic Analysis of the Ubiquitin Pathway across Cancer Types

49. Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas

50. Systematic Analysis of Splice-Site-Creating Mutations in Cancer

Catalog

Books, media, physical & digital resources